Literature DB >> 956694

Selective diphenylhydantoin-induced suppression of lymphocyte reactivity in vitro.

A Bluming, S Homer, R Khiroya.   

Abstract

Diphenylhydantoin (DPH) in concentrations approximating therapeutic blood levels was found to inhibit mixed lymphocyte culture (MLC) proliferation as measured by uptake of 3H-thymidine when compared to alkaline diluent required to solubilize the DPH. Control cultures containing diluent alone manifested inhibition of 3H-thymidine uptake relative to non-diluent-containing cultures. Both reactor and stimulator cells were independently capable of effecting this inhibition after treatment with DPH. An inconsistent effect of DPH on lymphocyte reactivity to graded doses of phytohemagglutinin and to pokeweed mitogen was observed. A possible association between the effect of DPH on MLC reactivity and the phenomenon of dilantin-induced lymphadenopathy is suggested.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 956694

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  5 in total

1.  The effects of phenytoin on T-lymphocyte enumeration [proceedings].

Authors:  C Hornby; P W Mullen
Journal:  Br J Pharmacol       Date:  1977-11       Impact factor: 8.739

2.  Response to transfer factor to immunodeficiency in handicaps treated with phenytoin.

Authors:  T Ikeda; A Higashi; I Matsuda; S Miyoshino
Journal:  Eur J Pediatr       Date:  1979-09       Impact factor: 3.183

3.  Delayed cutaneous hypersensitivity in children with severe multiple handicaps treated with phenytoin.

Authors:  A Higashi; I Matsuda; S Sinosuka; H Ohtsuka; F Endo; T Maeda; T Ikeda; S Miyoshino
Journal:  Eur J Pediatr       Date:  1978-12-01       Impact factor: 3.183

4.  Diphenylhydantoin (DPH) blocks HIV-receptor on T-lymphocyte surface.

Authors:  J P Zimmer; H A Lehr; M E Kornhuber; D Breitig; L Montagnier; K Gietzen
Journal:  Blut       Date:  1986-12

5.  Effects of phenytoin on cell-mediated immunity.

Authors:  Y Okamoto; K Shimizu; K Tamura; Y Miyao; M Yamada; N Tsuda; Y Matsui; H Mogami
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.